UBS Upgrades GE HealthCare: $88 Price Target Plan

UBS Upgrades GE HealthCare Technologies to Neutral, Raises Price Target

On Monday, UBS made a notable change in its stance on GE HealthCare Technologies Inc. (NASDAQ:GEHC), shifting the rating from Sell to Neutral. The firm also increased the stock’s price target to $88, up from the previous target of $66. This upgrade comes as UBS analysts acknowledge the company’s credible strategies for margin improvement.